Signal

From REITs to retail to supplements, capital is flooding into wellness from every direction — here's what fitness operators need to do before they're the last ones at the table.

We read the guidelines, the meta-analyses and the safety data. Vitamin D is a correction supplement, not a performance supplement — here's how a coach tells the difference, and the script for the client who's already taking 5,000 IU.

From Peloton's drive-by high fives to P&G's $3.8B bet on wellness, the industry is dividing fast — here's how to position before the gap widens.

From UK city rankings to P&G's $3.8bn bet, this week's signals all point to the same uncomfortable truth: wellness money is moving fast, and most operators are watching from the sidelines.

We read the meta-analyses on sleep and performance, graded them, and checked what's still being tested. What sleep loss actually costs a training block, what a nap is worth, and exactly what to tell the client who says they're fine on six hours.

P&G just spent $3.8bn to own your customer's medicine cabinet — here's how independent fitness operators stay relevant before the giants lock up the whole stack.

From a $67M real estate deal to a $10M digital health raise, capital is chasing a very specific kind of fitness operator right now — here's what they all have in common.

From Italian mega-rollouts to village crowdfunders, the fitness industry is fracturing along a fault line that will determine who survives the next five years.

Six stories this week reveal the same truth: the operators and investors winning right now are obsessing over who they serve, not just how many.

We read the meta-analyses and graded them. What ashwagandha does for stress, sleep and strength, what's oversold, the real liver-and-pregnancy caution, and exactly what to tell the client who asks.

We read the umbrella reviews, the ISSN position stand, and the newest trials, and graded them. What caffeine really does for performance, the dose that works, and the honest downsides — written for the gym floor.

We read the body-composition trials on Ozempic, Wegovy and Mounjaro, graded them, and checked what's still being tested. How much muscle GLP-1 drugs really cost, why the panic is half-right, and precisely what to program for the client who's dropping weight fast.

Three signals from this week show exactly what private equity, community programs, and European market data have in common — and what smart operators should do about it.

The 'healing and growth' peptides are all over gym WhatsApp groups. We read the actual human evidence — and mostly found its absence. What BPC-157, TB-500 and the growth-hormone peptides really have behind them, why the risk sits with your client, and exactly how to have the conversation.

We read the Finnish cohort studies, the intervention trials, and the recovery research, and graded them. What heat exposure really does for the heart and for training, where the longevity story is over-read, and exactly what to tell the client who asks.

We pulled the mortality cohorts, the inflammation RCTs, the Cochrane review and the one trial the internet loves — graded them all — and worked out what a coach should actually tell a client who just threw out their canola oil. Spoiler: the evidence points the opposite way to the panic.

The DACH fitness market's latest data drop and a European champion's story reveal the same growth lever operators keep ignoring.

We read the meta-analyses on cold water immersion, graded them, and checked the live trial registry. What it does for recovery, what it costs you in muscle, and exactly what to tell the client who just bought an ice barrel.

New DACH industry data and a European champion's story reveal the gap most fitness operators are ignoring — and exactly how to close it.

The German-speaking fitness market is growing fast — but the operators who win will be the ones who turn local champions into magnetic brand assets.

The DACH fitness market is on a hot streak, and the operators who add contrast hydrotherapy now will own the margin everyone else is chasing.

We read the meta-analyses, graded them, and checked what's still being tested. What magnesium really does, which form to bother with, and exactly what to tell the client who asks.

How contrast hydrotherapy and fresh DACH market data point to the same uncomfortable truth: recovery is now the retention lever fitness operators can't ignore.

How contrast hydrotherapy and the biology of stress decisions point to one overlooked recovery tool for fitness operators.

The real industry anchor is 66.4% annual retention — not the decade-old 71.4% everyone still quotes. Enter your number and see where you actually stand. A living Sqwod Intelligence report.

Wellness is the one category consumers plan to spend MORE on in 2026 — and recovery is its broadest door.

The market is ~$91bn (2026) growing ~8%/yr per GMInsights — but units grow far slower than value, and smart rings are the fastest-growing slice. A fully-sourced, living Sqwod Intelligence report.